Valuation
Login to View
Max Portfolio %
Login to View
IMGN RSI Chart
Valuation
Login to View
Max Portfolio %
Login to View
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Historical Charts for Stock Metrics
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2023 | 120.6M | 189.6M | 287.6M | 0 |
| 2022 | 92.2M | 89.4M | 95.6M | 108.8M |
| 2021 | 134.7M | 136.6M | 127.7M | 69.9M |
| 2020 | 87.0M | 86.5M | 91.4M | 132.3M |
| 2019 | 42.2M | 48.5M | 50.8M | 82.3M |
| 2018 | 106.8M | 77.0M | 79.5M | 53.4M |
| 2017 | 57.4M | 89.0M | 89.8M | 115.4M |
| 2016 | 65.2M | 60.0M | 52.8M | 48.6M |
| 2015 | 78.7M | 85.5M | 87.2M | 56.9M |
| 2014 | 58.0M | 59.9M | 55.9M | 74.1M |
| 2013 | 34.7M | 35.5M | 48.7M | 76.1M |
| 2012 | 19.9M | 16.4M | 17.9M | 12.9M |
| 2011 | 18.0M | 19.3M | 18.4M | 21.9M |
| 2010 | 0 | 13.9M | 15.3M | 16.6M |
| Â CEO | Mr. Mark Joseph Enyedy |
|---|---|
| Â WEBSITE | immunogen.com |
| Â SECTOR | Healthcare |
| Â INDUSTRY | Biotechnology |
| Â EMPLOYEES | 277 |